UBS Group AG - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$709,923
-67.7%
30,706
-63.4%
0.00%
-100.0%
Q2 2023$2,200,775
-0.9%
83,935
-2.7%
0.00%0.0%
Q1 2023$2,220,745
-42.7%
86,276
-42.1%
0.00%0.0%
Q4 2022$3,878,507
+178.0%
149,116
+204.9%
0.00%0.0%
Q3 2022$1,395,000
-30.9%
48,912
-40.3%
0.00%0.0%
Q2 2022$2,018,000
-57.4%
81,947
-2.3%
0.00%
-50.0%
Q1 2022$4,735,000
+206.7%
83,904
+236.8%
0.00%
Q4 2021$1,544,000
-43.3%
24,913
-42.0%
0.00%
-100.0%
Q3 2021$2,725,000
+1235.8%
42,960
+1635.8%
0.00%
Q2 2021$204,000
-94.0%
2,475
-94.6%
0.00%
-100.0%
Q1 2021$3,392,000
+2207.5%
46,108
+2186.0%
0.00%
Q4 2020$147,000
+539.1%
2,017
+323.7%
0.00%
Q3 2020$23,000
+130.0%
476
+22.7%
0.00%
Q1 2020$10,000
-88.9%
388
-83.4%
0.00%
Q4 2019$90,000
+76.5%
2,340
-0.2%
0.00%
Q3 2019$51,0002,3440.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders